Stem cell-derived hepatocyte-like cells hold great potential for the treatment of liver disease and for drug toxicity screening. The success of these applications hinges on the generation of differentiated cells with high liver specific activities. Many protocols have been developed to guide human embryonic stem cells (hESCs) to differentiate to the hepatic lineage. Here we report cultivation of hESCs as three-dimensional aggregates that enhances their differentiation to hepatocyte-like cells. Differentiation was first carried out in monolayer culture for 20 days. Subsequently cells were allowed to self-aggregate into spheroids. Significantly higher expression of liver-specific transcripts and proteins, including Albumin, phosphoenolpyruvate carboxykinase, and asialoglycoprotein receptor 1 was observed. The differentiated phenotype was sustained for more than 2 weeks in the three-dimensional spheroid culture system, significantly longer than in monolayer culture. Cells in spheroids exhibit morphological and ultrastructural characteristics of primary hepatocytes by scanning and transmission electron microscopy in addition to mature functions, such as biliary excretion of metabolic products and cytochrome P450 activities. This three-dimensional spheroid culture system may be appropriate for generating high quality, functional hepatocyte-like cells from ESCs.
Get full access to this article
View all access options for this article.
References
1.
JeonH and LeeSG. (2010). Living donor liver transplantation. Curr Opin Organ Transplant, 15:283–287.
2.
HughesRD, MitryRR and DhawanA. (2012). Current status of hepatocyte transplantation. Transplantation, 93:342–347.
3.
SoltysKA, Soto-GutierrezA, NagayaM, BaskinKM, DeutschM, ItoR, ShneiderBL, SquiresR, VockleyJ, et al. (2010). Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol, 53:769–774.
4.
CarpentierB, GautierA and LegallaisC. (2009). Artificial and bioartificial liver devices: present and future. Gut, 58:1690–1702.
5.
NybergSL. (2012). Bridging the gap: advances in artificial liver support. Liver Transpl, 18 Suppl 2:S10–S14.
6.
HaridassD, NarainN and OttM. (2008). Hepatocyte transplantation: waiting for stem cells. Curr Opin Organ Transplant, 13:627–632.
7.
SartipyP, BjorquistP, StrehlR and HyllnerJ. (2007). The application of human embryonic stem cell technologies to drug discovery. Drug Discov Today, 12:688–699.
8.
DalgettyDM, MedineCN, IredaleJP and HayDC. (2009). Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol, 297:G241–G248.
9.
JensenJ, HyllnerJ and BjorquistP. (2009). Human embryonic stem cell technologies and drug discovery. J Cell Physiol, 219:513–519.
10.
ImamuraT, CuiL, TengR, JohkuraK, OkouchiY, AsanumaK, OgiwaraN and SasakiK. (2004). Embryonic stem cell-derived embryoid bodies in three-dimensional culture system form hepatocyte-like cells in vitro and in vivo. Tissue Eng, 10:1716–1724.
11.
RoelandtP, PauwelynKA, Sancho-BruP, SubramanianK, BoseB, OrdovasL, VanuytselK, GeraertsM, FirpoM, et al. (2010). Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS One, 5:e12101
12.
AgarwalS, HoltonKL and LanzaR. (2008). Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells, 26:1117–1127.
13.
Si-TayebK, NotoFK, NagaokaM, LiJ, BattleMA, DurisC, NorthPE, DaltonS and DuncanSA. (2009). Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology, 51:297–305.
14.
TouboulT, HannanNR, CorbineauS, MartinezA, MartinetC, BranchereauS, MainotS, Strick-MarchandH, PedersenR, et al. (2010). Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology, 51:1754–1765.
15.
SnykersS, De KockJ, RogiersV and VanhaeckeT. (2009). In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art. Stem Cells, 27:577–605.
16.
AsgariS, MoslemM, Bagheri-LankaraniK, PournasrB, MiryounesiM and BaharvandH. (2011). Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells. Stem Cell Rev, 9:493–504.
17.
ChenYF, TsengCY, WangHW, KuoHC, YangVW and LeeOK. (2012). Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology, 55:1193–1203.
18.
PeshwaMV, WuFJ, SharpHL, CerraFB and HuWS. (1996). Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids. In Vitro Cell Dev Biol Anim, 32:197–203.
19.
TostoesRM, LeiteSB, SerraM, JensenJ, BjorquistP, CarrondoMJ, BritoC and AlvesPM. (2012). Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology, 55:1227–1236.
20.
SubramanianK, OwensDJ, O'BrienTD, VerfaillieCM and HuWS. (2011). Enhanced differentiation of adult bone marrow-derived stem cells to liver lineage in aggregate culture. Tissue Eng Part A, 17:2331–2341.
21.
TzanakakisES, HsiaoCC, MatsushitaT, RemmelRP and HuWS. (2001). Probing enhanced cytochrome P450 2B1/2 activity in rat hepatocyte spheroids through confocal laser scanning microscopy. Cell Transplant, 10:329–342.
22.
BravoP, BenderV and CassioD. (1998). Efficient in vitro vectorial transport of a fluorescent conjugated bile acid analogue by polarized hepatic hybrid WIF-B and WIF-B9 cells. Hepatology, 27:576–583.
23.
Oude ElferinkRP, MeijerDK, KuipersF, JansenPL, GroenAK and GroothuisGM. (1995). Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta, 1241:215–268.
24.
TakayamaK, InamuraM, KawabataK, SugawaraM, KikuchiK, HiguchiM, NagamotoY, WatanabeH, TashiroK, et al. (2012). Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1alpha transduction. J Hepatol, 57:628–636.
25.
WeaverVM, LelievreS, LakinsJN, ChrenekMA, JonesJC, GiancottiF, WerbZ and BissellMJ. (2002). beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell, 2:205–216.
26.
FrithJE, ThomsonB and GeneverPG. (2010). Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods, 16:735–749.
27.
SimaoD, CostaI, SerraM, SchwarzJ, BritoC and AlvesPM. (2011). Towards human central nervous system in vitro models for preclinical research: strategies for 3D neural cell culture. BMC Proc, 5 Suppl 8:P53
28.
LandryJ, BernierD, OuelletC, GoyetteR and MarceauN. (1985). Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol, 101:914–923.
29.
KelmJM, TimminsNE, BrownCJ, FusseneggerM and NielsenLK. (2003). Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng, 83:173–180.
30.
KellerPJ, PampaloniF and StelzerEH. (2006). Life sciences require the third dimension. Curr Opin Cell Biol, 18:117–124.
31.
GriffithLG and SwartzMA. (2006). Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol, 7:211–224.
32.
CukiermanE, PankovR, StevensDR and YamadaKM. (2001). Taking cell-matrix adhesions to the third dimension. Science, 294:1708–1712.
33.
Abu-AbsiSF, FriendJR, HansenLK and HuWS. (2002). Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res, 274:56–67.
34.
LeiteSB, Wilk-ZasadnaI, ZaldivarJM, AirolaE, Reis-FernandesMA, MennecozziM, Guguen-GuillouzoC, ChesneC, GuillouC, AlvesPM and CoeckeS. (2012). Three-dimensional HepaRG model as an attractive tool for toxicity testing. Toxicol Sci, 130:106–116.
35.
TsuchiyaA, HeikeT, FujinoH, ShiotaM, UmedaK, YoshimotoM, MatsudaY, IchidaT, AoyagiY and NakahataT. (2005). Long-term extensive expansion of mouse hepatic stem/progenitor cells in a novel serum-free culture system. Gastroenterology, 128:2089–2104.
36.
LazarA, MannHJ, RemmelRP, ShatfordRA, CerraFB and HuWS. (1995). Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel. In Vitro Cell Dev Biol Anim, 31:340–346.
37.
WuFJ, FriendJR, HsiaoCC, ZillioxMJ, KoWJ, CerraFB and HuWS. (1996). Efficient assembly of rat hepatocyte spheroids for tissue engineering applications. Biotechnol Bioeng, 50:404–415.
38.
NakamuraN, SaekiK, MitsumotoM, MatsuyamaS, NishioM, HasegawaM, MiyagawaY, OhkitaH, KiyokawaN, et al. (2012). Feeder-free and serum-free production of hepatocytes, cholangiocytes, and their proliferating progenitors from human pluripotent stem cells: application to liver-specific functional and cytotoxic assays. Cell Reprogram, 14:171–185.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
